Conference Reports

Los Angeles, California
19 February 2020 - 21 February 2020
San Francisco, California, US
13 February 2020 - 15 February 2020
Grapevine, Texas, US
03 February 2020 - 08 February 2020
Austin, Texas, US
23 January 2020 - 25 January 2020
Orlando, Florida
12 December 2019 - 14 January 2020
Orlando, Florida, US
07 December 2019 - 10 December 2019
Philadelphia, Pennsylvania, US
16 November 2019 - 18 November 2019
Singapore
08 November 2019 - 10 November 2019
22 November 2019 - 24 November 2019
Madrid
28 September 2019 - 02 October 2019
Barcelona
27 September 2019 - 01 October 2019
Barcelona, Spain
16 September 2019 - 20 September 2019
San Francisco, California, US
25 September 2019 - 29 September 2019
Mexico City, Mexico
21 July 2019 - 24 July 2019
Philadelphia, Pennsylvania
11 July 2019 - 14 July 2019
Los Angeles, California, US
14 July 2019 - 18 July 2019
Madrid, Spain
12 June 2019 - 15 June 2019
San Francisco, California
07 June 2019 - 11 June 2019
Chicago, Illinois, US
31 May 2019 - 04 June 2019
Pasay City
22 May 2019 - 26 May 2019
Dallas, Texas, US
17 May 2019 - 22 May 2019
Philadelphia, Pennsylvania
04 May 2019 - 10 May 2019
Baltimore, Maryland
24 April 2019 - 01 May 2019
Amsterdam, The Netherlands
13 April 2019 - 16 April 2019
Geneva, Switzerland
10 April 2019 - 13 April 2019
Vienna, Austria
10 April 2019 - 14 April 2019
Atlanta, Georgia
29 March 2019 - 03 April 2019
Lisbon, Portugal
17 March 2019 - 19 March 2019
New Orleans, Louisiana
16 March 2019 - 18 March 2019
Washington DC, US
01 March 2019 - 05 March 2019
New Orleans, Louisiana, US
23 March 2019 - 26 March 2019
Honolulu, Hawaii, US
06 February 2019 - 08 February 2019
19 January 2019 - 20 January 2019
Orlando, Florida, US
13 December 2018 - 15 December 2018
Vienna, Austria
12 December 2018 - 15 December 2018
San Antonio, Texas
04 December 2018 - 08 December 2018
San Diego, California, US
01 December 2018 - 04 December 2018
Singapore
23 November 2018 - 25 November 2018
Kuala Lumpur
22 November 2018 - 25 November 2018
Chicago, Illinois, US
10 November 2018 - 12 November 2018
Munich
19 October 2018 - 23 October 2018
Bangkok, Thailand
28 September 2018 - 01 October 2018
Munich
25 August 2018 - 29 August 2018
Surabaya
08 August 2018 - 11 August 2018
Amsterdam, the Netherlands
23 July 2018 - 27 July 2018
Orlando, Florida, US
22 June 2018 - 26 June 2018
Stockholm, Sweden
14 June 2018 - 17 June 2018
Amsterdam
13 June 2018 - 16 June 2018
San Diego, California, US
18 May 2018 - 23 May 2018
Los Angeles, California, US
21 April 2018 - 27 April 2018
Chicago, Illinois, US
14 April 2018 - 18 April 2018
Geneva
11 April 2018 - 14 April 2018
Barcelona
18 March 2018 - 20 March 2018
Chicago, Illinois, US
16 March 2018 - 20 March 2018
Copenhagen
16 March 2018 - 19 March 2018
Hong Kong
10 March 2018 - 11 March 2018
Orlando, Florida
10 March 2018 - 12 March 2018
San Diego, California
16 February 2018 - 20 February 2018
Las Vegas, Nevada
18 January 2018 - 20 January 2018
Los Angeles, California, US
24 January 2018 - 26 January 2018
San Francisco, California, US
18 January 2018 - 20 January 2018
Hong Kong
20 January 2018 - 20 January 2018
Abu Dhabi
04 December 2017 - 08 December 2017
Atlanta, Georgia, US
09 December 2017 - 12 December 2017
San Antonio, Texas, US
05 December 2017 - 09 December 2017
Anaheim, California, US
11 November 2017 - 15 November 2017
Singapore
17 November 2017 - 19 November 2017
Singapore
06 October 2017 - 08 October 2017
Milan, Italy
09 September 2017 - 13 September 2017
Singapore
13 July 2017 - 15 July 2017
San Diego, California, US
09 June 2017 - 13 June 2017
Chicago, Illinois, US
02 June 2017 - 06 June 2017
Geneva
05 May 2017 - 08 May 2017
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 27 Mar 2020
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 31 Mar 2020
Treatment with hydroxychloroquine appears to significantly reduce viral load in patients with the novel coronavirus disease (COVID-19), with its beneficial effects reinforced by adding azithromycin, results of a recent study have shown.
Elvira Manzano, 22 Nov 2017
A blood pressure (BP) reading of 130/80 mm Hg or higher is the ‘new high’ in the latest AHA/ACC* hypertension guidelines, a threshold that is tighter than the JNC 7** cutpoint of 140/90 mm Hg for stage 1 hypertension in the general population. The change will mean more patients being labelled with hypertension.
Audrey Abella, 27 Mar 2020
The angiotensin receptor blocker (ARB) losartan did not improve inflammation, T-cell immune recovery, or fibrotic activity among older persons living with HIV (PLHIV) and viral suppression, according to data presented at CROI 2020.